


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.14%
+0.19%
+1.56%
CLOV
Clover Health
$2.51
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Outperform the market
Chart
$2.63 (-4.56%)
$2.65 (-5.28%)
$2.97 (-15.49%)
$3.36 (-25.30%)
CLOV has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

CLOV overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
CLOV Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CLOV Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is CLOV current stock price?
What are CLOV stock strengths?
What risks are associated with CLOV stock?
When is CLOV next earnings report?
What is CLOV market cap and volume?
What is CLOV's current Stock IQ?
Should I buy CLOV stock right now?
Is CLOV a Strong Buy right now?
What does a 'Strong Buy' rating mean for CLOV?
What does a 'Strong Sell' rating mean for CLOV?
What factors influence CLOV's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.14%
+0.19%
+1.56%
CLOV
Clover Health
Current Price
$2.51
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Outperform the market

Chart
$2.63 (-4.56%)
$2.65 (-5.28%)
$2.97 (-15.49%)
$3.36 (-25.30%)
CLOV Analysts Opinion
CLOV Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
CLOV Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CLOV Street Sentiment is bullish and have positive views on the near-term outlook
CLOV has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Average key support and resistance price levels.
CLOV Latest Analysis
Clover Health Investments Corp. (CLOV) Presents at UBS Global Healthcare Conference 2025 Transcript.
Tue Nov 11, 2025
Canaccord Genuity Maintains Clover Health Investments (CLOV) Buy Recommendation. Fintel reports that on November 6 2025 Canaccord Genuity maintained coverage of Clover Health Investments (NasdaqGS:CLOV) with a Buy recommendation. Analyst Price Forecast Suggests 31.82% Upside
Fri Nov 7, 2025
Why Fast-paced Mover Clover Health Investments (CLOV) Is a Great Choice for Value Investors. Clover Health Investments (CLOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our Fast-Paced Momentum at a Bargain screen.
Thu Nov 6, 2025
CLOV Q3 Earnings Miss Stock Falls on Raised Insurance BER View. Clover Healths Q3 sales soar 50% but higher Insurance costs and a raised BER outlook weigh on investor sentiment.
Wed Nov 5, 2025
Clover Health down despite hike to revenue outlook.
Wed Nov 5, 2025
Clover Health GAAP EPS of -$0.05 misses by $0.02 revenue of $496.7M beats by $25.62M.
Tue Nov 4, 2025
Clover Health: Clinical Excellence To Fuel SaaS Growth Beyond The Star Downgrade.
Wed Oct 29, 2025
Clover Health (CLOV) Soars 41% as Analyst Goes Buy. We recently published 10 of Wall Streets Outperformers. Clover Health Investments Corp. (NASDAQ:CLOV) is one of the top-performing stocks last week. Clover Health saw its share prices soar by 40.96 percent week-on-week as investors took heart from a buy recommendation from an investment firm. In a market note Zacks Research upgraded Clover Health Investments Corp. [….]
Mon Oct 27, 2025
Clover Health Investments Reaches Analyst Target Price. In recent trading shares of Clover Health Investments Corp (Symbol: CLOV) have crossed above the average analyst 12-month target price of $3.77 changing hands for $3.82/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: down
Mon Oct 27, 2025
Clover Health Investments (CLOV) Upgraded to Buy: Heres What You Should Know. Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Thu Oct 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CLOV Stock trends
CLOV Stock performance
CLOV Stock analysis
CLOV investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.